Atrial fibrillation is an independent predictor for in-hospital mortality in patients admitted with SARS-CoV-2 infection

Chugh, 2014, Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study, Circulation, 129, 837, 10.1161/CIRCULATIONAHA.113.005119

Colilla, 2013, Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population, Am J Cardiol, 112, 1142, 10.1016/j.amjcard.2013.05.063

Zoni-Berisso, 2014, Epidemiology of atrial fibrillation: European perspective, Clin Epidemiol, 6, 213, 10.2147/CLEP.S47385

McManus, 2012, An update on the prognosis of patients with atrial fibrillation, Circulation, 126, e143, 10.1161/CIRCULATIONAHA.112.129759

Chiang, 2012, Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real- life global survey evaluating patients with atrial fibrillation international registry, Circ Arrhythm Electrophysiol, 5, 632, 10.1161/CIRCEP.112.970749

Clarke, 1997, Haemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation, J Am Coll Cardiol, 30, 1039, 10.1016/S0735-1097(97)00254-4

Bilaloglu, 2020, Thrombosis in hospitalized patients with COVID-19 in a New York City health system, JAMA, 324, 799, 10.1001/jama.2020.13372

Austin, 2009, Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research, Commun Stat Simul Comput, 38, 1228, 10.1080/03610910902859574

Austin, 2011, Comparing paired vs non-paired statistical methods of analyses when making inferences about absolute risk reductions in propensity-score matched samples, Stat Med, 30, 1292, 10.1002/sim.4200

Sanyaolu

Walkey, 2013, Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: incidence and risk factors, Am Heart J, 165, 949, 10.1016/j.ahj.2013.03.020

Walkey, 2011, Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis, JAMA, 306, 2248, 10.1001/jama.2011.1615

Bhatla, 2020, COVID-19 and cardiac arrhythmias, Heart Rhythm, 17, 1439, 10.1016/j.hrthm.2020.06.016

Benjamin, 1998, Impact of atrial fibrillation on the risk of death: the Framingham Heart Study, Circulation, 98, 946, 10.1161/01.CIR.98.10.946

Stewart, 2002, A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study, Am J Med, 113, 359, 10.1016/S0002-9343(02)01236-6

Andersson, 2013, All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case- control study, Eur Heart J, 34, 1061, 10.1093/eurheartj/ehs469

Mountantonakis, 2012, Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of Get With The Guidelines-Heart Failure, Circ Heart Fail, 5, 191, 10.1161/CIRCHEARTFAILURE.111.965681

Gandhi, 2015, New-onset atrial fibrillation in sepsis is associated with increased morbidity and mortality, Neth Heart J, 23, 82, 10.1007/s12471-014-0641-x

Kumar, 2010, Atrial fibrillation is more frequent in patients with severe sepsis and septic shock predicts a worse outcome, Chest, 138, 899, 10.1378/chest.10022

Wells, 2011, Incidence and prognosis of atrial fibrillation in patients with sepsis, Cardiol Res, 2, 293

Lau, 2009, Prognostic impact of types of atrial fibrillation in acute coronary syndromes, Am J Cardiol, 104, 1317, 10.1016/j.amjcard.2009.06.055

Sahu, 2020, C-reactive protein: a promising biomarker for poor prognosis in COVID-19 infection, Clin Chim Acta, 509, 91, 10.1016/j.cca.2020.06.013

Yamada, 2020, Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): a systematic review and meta-analysis, Clin Chim Acta, 509, 235, 10.1016/j.cca.2020.06.008

Yao, 2020, D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study, J Intensive Care, 8, 49, 10.1186/s40560-020-00466-z

Sweeney, 2018, It takes two: endothelial-perivascular cell cross-talk in vascular development and disease, Front Cardiovasc Med, 5, 154, 10.3389/fcvm.2018.00154

Stark, 2013, Capillary and arteriolar pericytes attract innate leukocytes exiting through venules and ‘instruct’ them with pattern-recognition and motility programs, Nat Immunol, 14, 41, 10.1038/ni.2477

Kennedy-Lydon, 2017, Immune functions and properties of resident cells in the heart and cardiovascular system: pericytes, Adv Exp Med Biol, 1003, 93, 10.1007/978-3-319-57613-8_5

Granger, 2010, Microvascular responses to cardiovascular risk factors, Microcirculation, 17, 192, 10.1111/j.1549-8719.2009.00015.x

McKinney, 2014, Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling, Clin Sci (Lond), 126, 815, 10.1042/CS20130436

Jansen, 2018, Distinct patterns of atrial electrical and structural remodeling in angiotensin II mediated atrial fibrillation, J Mol Cell Cardiol, 124, 12, 10.1016/j.yjmcc.2018.09.011